List of Tables - Multiple Drug Resistance Bacterial Infection Treatment Market Size, Share, Trends And Forecast To 2032

Multiple Drug Resistance Bacterial Infection Treatment Market By Vector (Critical, Medium, High), By Drug Class (Cephalosporin, Beta Lactam, Beta Lactamase Inhibitors, Oxazolidinone, Cyclic Lipopeptide, Glycolipopeptides) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032

29 Jul 2017 Format

TABLE 1 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 2 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 3 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 4 Global Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 5 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 6 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 7 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 8 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 9 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 10 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 11 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 12 Global Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 13 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 14 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 15 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 16 North America Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 17 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 18 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 19 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 20 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 21 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 22 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 23 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 24 North America Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 25 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 26 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 27 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 28 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 29 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 30 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 31 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 32 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 33 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 34 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 35 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 36 U.S. Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 37 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 38 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 39 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 40 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 41 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 42 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 43 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 44 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 45 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 46 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 47 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 48 Canada Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 49 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 50 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 51 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 52 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 53 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 54 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 55 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 56 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 57 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 58 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 59 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 60 Rest of North America Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 61 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 62 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 63 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 64 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 65 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 66 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 67 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 68 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 69 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 70 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 71 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 72 UK and European Union Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 73 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 74 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 75 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 76 UK Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 77 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 78 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 79 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 80 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 81 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 82 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 83 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 84 UK Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 85 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 86 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 87 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 88 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 89 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 90 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 91 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 92 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 93 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 94 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 95 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 96 Germany Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 97 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 98 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 99 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 100 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 101 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 102 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 103 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 104 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 105 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 106 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 107 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 108 Spain Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 109 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 110 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 111 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 112 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 113 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 114 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 115 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 116 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 117 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 118 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 119 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 120 Italy Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 121 France Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 122 France Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 123 France Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 124 France Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 125 France Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 126 France Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 127 France Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 128 France Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 129 France Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 130 France Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 131 France Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 132 France Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 133 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 134 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 135 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 136 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 137 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 138 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 139 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 140 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 141 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 142 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 143 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 144 Rest of Europe Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 145 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 146 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 147 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 148 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 149 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 150 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 151 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 152 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 153 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 154 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 155 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 156 Asia Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 157 China Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 158 China Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 159 China Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 160 China Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 161 China Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 162 China Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 163 China Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 164 China Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 165 China Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 166 China Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 167 China Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 168 China Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 169 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 170 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 171 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 172 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 173 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 174 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 175 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 176 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 177 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 178 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 179 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 180 Japan Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 181 India Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 182 India Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 183 India Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 184 India Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 185 India Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 186 India Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 187 India Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 188 India Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 189 India Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 190 India Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 191 India Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 192 India Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 193 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 194 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 195 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 196 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 197 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 198 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 199 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 200 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 201 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 202 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 203 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 204 Australia Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 205 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 206 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 207 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 208 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 209 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 210 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 211 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 212 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 213 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 214 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 215 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 216 South Korea Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 217 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 218 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 219 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 220 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 221 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 222 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 223 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 224 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 225 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 226 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 227 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 228 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 229 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 230 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 231 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 232 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 233 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 234 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 235 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 236 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 237 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 238 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 239 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 240 Brazil Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 241 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 242 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 243 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 244 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 245 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 246 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 247 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 248 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 249 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 250 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 251 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 252 Mexico Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 253 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 254 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 255 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 256 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 257 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 258 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 259 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 260 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 261 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 262 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 263 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 264 Rest of Latin America Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 265 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 266 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 267 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 268 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 269 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 270 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 271 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 272 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 273 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 274 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 275 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 276 Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 277 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 278 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 279 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 280 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 281 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 282 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 283 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 284 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 285 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 286 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 287 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 288 GCC Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 289 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 290 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 291 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 292 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 293 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 294 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 295 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 296 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 297 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 298 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 299 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 300 Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)
TABLE 301 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Vector, 2022-2032, USD (Million)
TABLE 302 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Critical, 2022-2032, USD (Million)
TABLE 303 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Medium, 2022-2032, USD (Million)
TABLE 304 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By High, 2022-2032, USD (Million)
TABLE 305 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 306 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Cephalosporin, 2022-2032, USD (Million)
TABLE 307 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactam, 2022-2032, USD (Million)
TABLE 308 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Beta Lactamase Inhibitors, 2022-2032, USD (Million)
TABLE 309 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Oxazolidinone, 2022-2032, USD (Million)
TABLE 310 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Cyclic Lipopeptide, 2022-2032, USD (Million)
TABLE 311 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Glycolipopeptides, 2022-2032, USD (Million)
TABLE 312 Rest of Middle East and Africa Multiple Drug Resistance Bacterial Infection Treatment Market By Others, 2022-2032, USD (Million)